Cancer clinical trials in the region Auvergne-Rhône-Alpes
366 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lung cancer
#NCT05609578
#2023-503714-77-00
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
None
Immunotherapy
Chemotherapy
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Mirati Thérapeutique Inc.
Phase 2
Prostate cancer
#NCT06395753
#2024-511038-11-00
Adenocarcinoma
Metastatic Hormone-sensitive
None
Systemic Treatment-Naive
Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA
Phase 2
Lymphoma
#NCT04984837
#2024-513252-15-00
T cell lymphoma
Peripheral T cell lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
Chemotherapy
Systemic Treatment-Naive
Allogeneic stem cell transplant
CHU Saint-Étienne (Saint-Priest-en-Jarez), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Hospitalier Métropole Savoie (Chambéry) (and 2 more...)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Breast cancer
#NCT06840483
#2024-517868-33-00
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Centre Léon Bérard (Lyon)
BicycleTx Limited
Phase 2
Kidney cancer
#NCT05096390
#2024-513986-38-00
Papillary carcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Centre Léon Bérard
Phase 2
Prostate cancer
#NCT06004661
Metastatic Castration-resistant
PSMA PET Positive
1
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Hôpital Louis Pradel (Bron )
Novartis
Phase 2
Prostate cancer
#NCT04536805
Biochemical recurrence
None
Surgery
Radiotherapy
Hormone therapy
Centre Léon Bérard (Lyon)
Institut de Cancérologie de l'Ouest
Phase 2
Lung cancer
#NCT05617963
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpitaux Nord-Ouest - Villefranche-sur-Saône (Gleizé), Centre Jean Perrin (Clermont Ferrand )
UNICANCER
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04954820
Neuroendocrine tumor
1
Systemic Treatment-Naive
Systemic Treatment-Naive
CHU Saint-Étienne (Saint-Priest-en-Jarez), Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron ), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Hospitalier Métropole Savoie (Chambéry) (and 1 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT06511648
Invasive bladder cancer
Urothelial carcinoma
Localized
Locally Advanced
FGFR
None
Systemic Treatment-Naive
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Radiotherapy
Centre Jean Perrin (Clermont Ferrand )
Groupe espagnol d'oncologie génito-urinaire